D57.432 Sickle-cell thalassemia beta zero with splenic sequestration

Name of the Condition

• Sickle-cell thalassemia beta zero with splenic sequestration

Summary

Sickle-cell thalassemia beta zero with splenic sequestration is a genetic blood disorder resulting from the co-inheritance of sickle cell disease and beta zero thalassemia mutations. It causes red blood cells to become abnormal in shape and function, leading to complications such as anemia, pain, and organ damage. The presence of splenic sequestration indicates a severe complication involving the pooling of blood in the spleen, which can cause rapid splenic enlargement and life-threatening anemia.

Causes

Sickle-cell thalassemia arises from co-inheritance of mutations in the hemoglobin gene (HBB). One parent contributes a sickle cell mutation, while the other contributes a beta zero thalassemia mutation. This combination alters hemoglobin structure, resulting in sickle-shaped red blood cells and reduced hemoglobin production.

Risk Factors

• Family history of sickle-cell disease or thalassemia
• Ethnic backgrounds with higher prevalence of these conditions (e.g., Mediterranean, Middle Eastern, Indian, or African descent)
• Inheriting one sickle cell gene and one beta zero thalassemia gene increases the risk of passing the disorder to offspring

Symptoms

• Fatigue and weakness due to anemia
• Jaundice (yellowing of the skin or eyes)
• Swelling in hands and feet (dactylitis)
• Frequent infections
• Delayed growth or puberty in children
• Episodes of severe pain (vaso-occlusive crises)
• Sudden abdominal pain or fullness
• Rapid heart rate
• Low blood pressure
• Pale skin or mucous membranes

Diagnosis

Diagnosis involves blood tests to identify sickle-shaped red blood cells and hemoglobin abnormalities. Additional tests may include a complete blood count (CBC) to assess anemia, reticulocyte count, and hemoglobin electrophoresis to confirm the specific genetic mutations. Imaging studies, such as ultrasound, may be used to evaluate splenic size and detect sequestration.

Treatment Options

Treatment focuses on managing acute symptoms and preventing complications. This may include blood transfusions to address severe anemia, hydration, pain management, and antibiotics for infections. In cases of splenic sequestration, urgent medical intervention is required, often involving blood transfusions and monitoring for splenic rupture. Long-term management may include hydroxyurea to reduce sickle cell formation and vaccinations to prevent infections.

Prognosis and Follow-Up

Prognosis depends on the severity of the condition and timely intervention. Acute splenic sequestration can be life-threatening but is often manageable with prompt treatment. Long-term follow-up is essential to monitor for complications, such as organ damage or recurrent sequestration episodes. Regular check-ups and adherence to treatment plans can improve outcomes.

Complications

• Severe anemia
• Splenic infarction or rupture
• Organ damage (e.g., liver, kidneys)
• Increased risk of infections
• Vaso-occlusive crises
• Stroke
• Pulmonary hypertension

Lifestyle & Prevention

• Stay hydrated to reduce the risk of sickle cell crises.
• Avoid extreme temperatures and high altitudes.
• Follow a balanced diet to support overall health.
• Engage in regular, moderate exercise as recommended by a healthcare provider.
• Ensure up-to-date vaccinations, especially for pneumococcal and influenza.
• Avoid smoking and limit alcohol consumption.

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Sudden severe abdominal pain
• Rapid heart rate or low blood pressure
• Pale skin or extreme fatigue
• Difficulty breathing
• Signs of infection (e.g., fever, chills)

Tips for Medical Coders

When coding for sickle-cell thalassemia beta zero with splenic sequestration (D57.432), ensure documentation clearly specifies the presence of splenic sequestration as a complication. Verify that the diagnosis aligns with the co-inheritance of sickle cell disease and beta zero thalassemia. Document any acute interventions, such as blood transfusions or imaging studies, to support the code assignment. Review clinical notes for specificity to confirm the condition and its associated complications.